Vedic Lifesciences begins clinical trial for US Dietary Supplement

Phase II studies to begin under Vedic Lifesciences for a US Dietary Supplement known to lower blood pressure and improve blood circulation. End Quote

(1888PressRelease) July 20, 2011 - Hypertension is the leading risk factor for premature death, responsible for 12.8% (7.5 million) of deaths worldwide, as well as causing up to 54% of cardiovascular deaths, according to a report from the World Health Organization published in 20101 Hypertension and its adverse effects are health problems of concern which have united researchers and Pharma companies worldwide to declare a scientific crusade against this malady.

Redwood Shores, CA, based Vedic Lifesciences which supports ongoing research in this Therapeutic area announced the start of a Phase II Study on LevodynTM by Nathans Natural. Manufactured under the highest standards and with U.S.

Pharmaceutical Grade ingredients, LevodynTM is known for its science to lower blood pressure, improve blood circulation, etc. The trial will be a double blind, randomized, placebo-controlled, parallel- group, multicentric study to evaluate the Efficacy and safety of this supplement in subjects with mild hypertension. Vedic has in the past served Nutraceutical companies for clinical trials in the segment of cardiovascular diseases. The Project Management team at Vedic assigned for this study has tremendous experience in setting up and managing multicentric cardiovascular trials.

Jayesh Chaudhary, CEO, Vedic Lifesciences, added that he was indeed pleased to welcome Nathans Natural and bring affordable solutions to supplement companies for claim substantiation conforming to FTC requirements.

Anthony Durazo, Founder, Nathans Natural commented," I was convinced about Vedic's credibility in managing my clinical trials, by looking at the past work which they have managed for US and Canadian Nutraceutical firms.

About Vedic Lifesciences
Founded in 2000, Vedic Lifesciences is a full service Contract Research Organization (CRO) serving the Nutraceutical industry worldwide. Serving the North American, Canadian and European market from its US office and the Asian subcontinent from India. Vedic Lifesciences has been catering to the research and regulatory needs of the Traditional Herbal Medicine, Chinese Medicine, Natural Health Products, Ayurvedic, Homeopathic and other alternative and complementary medicine industry since the last decade. Clinical Research data from Vedic has been accepted by Regulatory bodies worldwide and Clinical Research Papers published in top of the line peer reviewed journals.

Reference:
1. Mathers C, Stevens G, Mascarenhas M. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization; 2009.

###

space

Other Related Press Releases